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Abstract
Background: Tobacco use is projected to cause nearly 450 million deaths worldwide during the next 50 years. Health
professionals can have a critical role in reducing tobacco use. Therefore, one of the strategies to reduce the number of
smoking-related deaths is to encourage the involvement of health professionals in tobacco-use prevention and cessation
counseling. As future health care providers, pharmacy students should consider providing assistance to others to
overcome tobacco use and be involved in promoting a tobacco free future as part of their professional responsibility.
This research was to determine the knowledge of tobacco/smoking policy, willingness to be involved in tobacco
cessation, attitude to keeping a tobacco free environment and the smoking habit among pharmacy students at the
University of Lagos.
Methods: Data was collected by the use of self administered questionnaire which was aimed at assessing their smoking
habit, determining their knowledge and attitude to smoking policy and willingness to be involved in smoking cessation.
The population sample was all the pharmacy students in their professional years (200 to 500 Levels) at Idi-Araba Campus
of the University of Lagos.
Results: Out of 327 qualified participants, 297 responded to the questionnaire which was about 91% participation rate
but out of these only 291 questionnaires were useful which came to 89%.
There seemed to be no statistically significant difference between the smoking habits among the different levels (p > 0.05).
Overall, the current smoking prevalence was 5.5% which is lower than the national prevalence rate of 8.9%.
Awareness of WHO FCTC global tobacco treaty was low (9.3%) among pharmacy students but they agreed that
pharmacists and pharmacy students should be involved in quit smoking program (93.1%) and they were willing to be
involved in helping smokers to quit (85.9%). Majority agreed that smoking should not be permitted in pharmacies (87.9%)
and at pharmacy students' events (86.9%).
Conclusion: From this study it can be concluded that smoking prevalence is low among pharmacy students at the
University of Lagos. Awareness of global policy is low but they are willing to be involved in smoking cessation and
promoting a tobacco free future.
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Background
Tobacco use is the single largest cause of preventable
death in the world today. The WHO report on the global
tobacco epidemic, 2008 [1] provides a comprehensive anal-
ysis, based on data from 135 countries, of patterns of
tobacco use, the deaths that result and the measures to
reduce deaths.
Tobacco kills a third to a half of all those who use it. On
average, every user of tobacco loses 15 years of life. Total
tobacco-attributable deaths from ischaemic heart disease,
cerebrovascular disease (stroke), chronic obstructive pul-
monary disease and other diseases are projected to rise
from 5.4 million in 2004 to 8.3 million in 2030, almost
10% of all deaths worldwide. More than 80% of these
deaths will occur in developing countries [1].
Tobacco use is highly prevalent in many countries.
According to estimates for 2005, 22% of adults worldwide
currently smoke tobacco. Some 36% of men smoke com-
pared to 8% of women [2].
WHO recommends five policies for controlling tobacco
use: smoke-free environments; support programmes for
tobacco users who wish to stop; health warnings on
tobacco packs; bans on the advertising, promotion and
sponsorship of tobacco; and higher taxation of tobacco.
About half of all countries in the world implement none
of these five recommended policies, despite the fact that
tobacco control measures are cost-effective and proven.
Moreover, not more than 5% of the world's population is
fully covered by any one of these measures [2].
The World Health Organization has estimated that
tobacco and its products kill over 3.5 million people
worldwide every year and it is extrapolated that by the
decade 2020–2030, tobacco will kill 10 million people a
year [3].
The World Health Organization Framework Convention
on Tobacco Control (WHO FCTC) is a global public
health treaty aimed at reducing the burden of disease and
death caused by tobacco consumption. The WHO Frame-
work Convention for Tobacco Control (WHO-FCTC),
adopted by the 56th World Health Assembly in May 2003,
is the first international public health treaty on tobacco
control [4]. The Convention opened for signature on 16th
June 2003 in Geneva, Switzerland. The Convention
quickly became one of the most widely embraced treaties
in United Nations history; within two and a half years, it
boasted more than 100 Contracting Parties. It officially
entered into force in February 2005 and by the end of
2006, the total number of Parties had reached 149 cover-
ing more than three quarters of the world's population. At
present the Signatories to the WHO FCTC is 168 and the
Parties to the WHO FCTC is 166 [5]. It gives the interna-
tional community tools to stand up to tobacco giants,
decrease global addiction rates, and reverse the tobacco
epidemic.
The global tobacco treaty bans tobacco advertising, pro-
motion and sponsorship, and insulates public health pol-
icy from interference by tobacco corporations. The treaty's
advertising ban means an end to some of the tobacco
industry's most effective and deadly tactics, like Philip
Morris/Altria's Marlboro Man, in countries that ratify.
While Philip Morris/Altria, British American Tobacco
(BAT) and Japan Tobacco International (JTI) continue to
aggressively target developing countries to expand mar-
kets for their products, the tobacco giants are renewing
their efforts to derail the treaty process in countries
around the world.
The global tobacco treaty is a major victory for the corpo-
rate accountability movement. It sets important prece-
dents for regulating other abusive industries that profit at
the expense of people's health and the environment.
Tobacco use among health professionals is of particular
interest in the area of tobacco related surveillance since
they are not only responsible for primary health care and
education for tobacco related issues such as cessation and
exposure to second-hand tobacco smoke, but are also role
models in the community. Furthermore, the preamble of
the WHO FCTC emphasizes the role of health profes-
sional bodies in efforts to include tobacco control in the
public health agenda and contribute actively to the reduc-
tion of tobacco consumption. These activities are also
described in the Code of Practice for Health Professionals
which has been officially adopted now by several Health
Professional Associations worldwide [6].
Since 1987, the World Health Organization (WHO) has
sponsored World No Tobacco Day to encourage countries
to implement comprehensive programs to reduce tobacco
use. Involvement of health professionals in tobacco con-
trol is very importatnt such that the theme of World No
Tobacco Day 2005 was 'Health professionals against
tobacco'[7].
Pharmacists are healthcare providers involved in treating
and preventing illness and promoting health, and are
therefore central to achieving the tobacco cessation goals.
The Global Network of Pharmacists Against Tobacco,
established by the International Pharmaceutical Federa-
tion (FIP) in collaboration with the WHO EuroPharm
Forum, is a global forum for pharmacists, pharmaceutical
students and their professional organizations as well as
other individuals or organizations interested in smoking
cessation and tobacco control activities. The network was
officially launched during the World Conference onTobacco Induced Diseases 2009, 5:13 http://www.tobaccoinduceddiseases.com/content/5/1/13
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Tobacco or Health 2003 in Helsinki, Finland, in connec-
tion with the Pharmacists Special Session [8].
Since the launch of the Global Network of Pharmacists
Against Tobacco in Helsinki in August 2003, FIP has been
involved in many new Tobacco Cessation initiatives.
During the FIP Congress 2003 in Sydney, FIP adopted a
Statement of Policy on the Role of the Pharmacist in Pro-
moting a Tobacco Free Future. The statement includes rec-
ommendations both for pharmaceutical organizations
and for individual pharmacists to help people who wish
to give up smoking or other uses of tobacco, and to
encourage others to do so.
As a step towards the implementation of the Statement,
the FIP Council agreed to make a combined effort of all
FIP Member Organisations to mobilise pharmacists
around Tobacco Cessation. This issue was tackled through
a global campaign for pharmacists, launched on the
World No Tobacco Day on 31 May 2004.
As an offshoot of Code of Practice on Tobacco Control for
Health Professional Organisations a meeting of the FIP
Global Network of Pharmacists Against Tobacco was held
during the 64th FIP Congress in New Orleans, LA, USA,
which was attended by more than 70 pharmacists from 20
countries after which FIP issued a Press Release entitled
"FIP Calls for Ban on Tobacco Sales and Smoking in Phar-
macies".
A Joint Statement was made by the International Pharma-
ceutical Students' Federation (IPSF) and the European
Pharmaceutical Students' Association (EPSA) This joint
statement is based on the WHO Mandate in Public Health
and on the FIP Statement of Policy on the Role of the Pharma-
cist in Promoting a Tobacco Free Future. As future health care
providers, pharmacy students should take a proactive role
in developing initiatives designed to target the increasing
burden of tobacco use.
IPSF and EPSA recognise that pharmacy students, as role
models and future members of the health care team, have
a crucial role in promoting cessation of tobacco use. Col-
laboration with other heath care students and profes-
sional associations will help ensure a tobacco free future.
Pharmacy students and pharmacists should consider pro-
viding assistance to others to overcome this condition as
part of their professional responsibility.
Pharmacists have been involved in tobacco cessation
activities in some 14 countries [9-11].
Since students in healthcare profession are future profes-
sionals, basic information about tobacco smoking among
healthcare professional student population would be
important since their approach and credibility as future
treatment providers may be influenced by their own
smoking habits [12]. In a study carried out among health
profession students 86.6%–99.8% believed health profes-
sionals should advise patients about smoking cessation
however only 5.2%–36.6% among pharmacy students
had received formal training in tobacco cessation coun-
seling. Among these students 71.7% – 99.0% believed
that health professionals should be trained in cessation
techniques [13].
Objectives of the study were to assess the prevalence of
cigarette smoking among pharmacy students, assess the
awareness and attitude to tobacco/smoking control policy
and determine the willingness of pharmacy students at
the University of Lagos to be involved in tobacco cessation
and keeping a tobacco free environment.
Methods
Study Area
Study Area was Faculty of Pharmacy of the University of
Lagos, Nigeria.
Study Population
Study population was pharmacy students in their profes-
sional years (200 Level to 500 Level). The total student
population was 327 but at the end of the study only 297
students participated and 291 questionnaires were useful.
Study Design
A cross-sectional survey targeting the entire population
size
Study instrument
A well structured, pretested self administered question-
naire was used. The questionnaire of this study was devel-
oped based on the questionnaire of Global Health
Professional Survey (GHPS) [14].
The questionnaire consisted of demographic characteris-
tics (age, sex, level, and religion.), smoking behaviour and
attitudes (smoking status/prevalence, stage and age at
which smoking started, number of cigarettes smoked
daily), knowledge and attitude to smoking/tobacco policy
and curriculum/training,
Procedure for data collection
Consent of the students was sought before distribution of
questionaire. Questionnaires were distributed to the stu-
dents during lecture time. The questionnaires were filled
and retrieved same time.
Data Analysis
The information in the questionnaires was transferred
into Statistical Package for Social Sciences (SPSS 10) soft-Tobacco Induced Diseases 2009, 5:13 http://www.tobaccoinduceddiseases.com/content/5/1/13
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ware. Data analysis consisted of frequency analysis and
cross tabulation for Chi square (X2) test for statistical sig-
nificance.
Results
In this study out of 327 qualified participants, 297
responded to the questionnaire which was about 91%
participation rate but out of these only 291 questionnaires
were useful which came to 89%.
Overall smoking prevalence was 5.5% and all these were
males.
Figure 1 shows the percentage each level is contributing to
total respondents.
Majority of the respondents fell within the age bracket of
21–25 (58.1%) followed by age bracket 16–20 (29.6%).
Only one respondent was above 30 years of age represent-
ing a marginal 0.3% (Figure 2). There was statistically sig-
nificant difference in the age distribution between the
different levels of study (p < 0.05).
Among the respondents 62.5% were females while 37.5%
were males (Figure 3).
There was statistically significant difference in the sex dis-
tribution between the levels of study (p < 0.05).
Figure 4 shows the smoking status of those that had ever
smoked and those still smoking among them according to
level of study and sex. There was no statistically significant
difference in the smoking status of the different levels (p
> 0.05).
Among female respondents 8.8% of them had ever
smoked but none of these is still smoking while among
the male respondents 33.9% of them had ever smoked
and 43.2% of these are still smoking. There was statisti-
cally significant difference in the smoking status between
male and female respondents (p < 0.05). All the respond-
ents still smoking are males.
The current smoking status was highest in 200 level
(8.24%) and lowest in 300 level (3.16%) (Figure 5).
Majority started smoking at secondary school (39%) and
the lowest was in 300 level (Figure 6). There was no statis-
tically significant difference in the stage of starting smok-
ing among the different levels (p > 0.05).
Majority started smoking between ages 16–20 years
(62%) and the least were below 10 and above 20 years
(8%) (Figure 7). There was no statistically significant dif-
Percentage each level is contributing to total Respondents Figure 1
Percentage each level is contributing to total 
Respondents.
Age of respondents Figure 2
Age of respondents.
Sex of respondents Figure 3
Sex of respondents.Tobacco Induced Diseases 2009, 5:13 http://www.tobaccoinduceddiseases.com/content/5/1/13
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ference in the age of starting smoking between the differ-
ent levels of study (p > 0.05). At each level majority started
smoking between ages 16 – 20 years.
Majority were smoking between 1 – 5 cigarettes per day,
both among those that have stopped smoking (88.9%)
and those that are still smoking (93.7%).
Table 1 shows the positive responses to the awareness
questions. Overall 95.9% of them were aware of tobacco
induced diseases and at each level of study over 90% of
them were aware of tobacco induced diseases. There was
no statistically significant difference in the awareness of
tobacco induced diseases between the different levels (p >
0.05). Only about 9.0% were aware of World No Tobacco
Day. There was no statistically significant difference in the
awareness of world no tobacco day among the different
levels of study (p > 0.05). Among the respondents about
Respondents that had ever smoked and those that are still  smoking among them by level of study and sex Figure 4
Respondents that had ever smoked and those that 
are still smoking among them by level of study and 
sex.
Current smoking status by level of study Figure 5
Current smoking status by level of study.
Stage of starting smoking Figure 6
Stage of starting smoking.
Age of starting smoking Figure 7
Age of starting smoking.Tobacco Induced Diseases 2009, 5:13 http://www.tobaccoinduceddiseases.com/content/5/1/13
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6.3% were aware of Nigerian Tobacco Decree. There was
no statistically significant difference in the awareness of
Nigerian tobacco decree among the respondents in the
different levels of study (p > 0.05). Only about 9.3% were
aware of WHO FCTC. There was no statistically significant
difference in the awareness of WHO FCTC among the
respondents in the different levels of study (p > 0.05)
Table 2 shows agreement responses to willingness and
attitudinal questions.
About 94% agreed to the statement that it is their duty as
future health care providers to be involved in smoking
cessation programme while only 1.4% disagreed. At least
90% of the respondents agreed to this statement at each
level of study. There was no statistically significant differ-
ence in the level of agreement to this statement between
the levels of study (p > 0.05).
There was over 80% agreement to the willingness/attitudi-
nal questions except in the response to tobacco should
not be sold in pharmacies where the response was less
than 80%.
Also in all the agreement responses to willingness/attitu-
dinal questions there was no statistically significant differ-
ence among the levels of study except in the response to
tobacco should not be sold in pharmacies.
Discussion
The major objectives of this survey were to investigate the
prevalence of smoking habit among the entire pharmacy
students and to determine their awareness and attitude to
smoking policy and willingness to be involved in smoking
cessation. The overall current smoking prevalence was
5.5% among the respondents and all these were males.
This value is better than the report of studies carried out
among youths in Cross Rivers state of Nigeria where the
prevalence was 23.9% in males, 17.0% in females and
18.1% overall since the pharmacy students fall into the
age bracket of youth[15].
The students age group falling among youth is very impor-
tant to note such that they should be able to influence
their peers and the age group is so important that the
World no tobacco day for last year (2008) was 'Tobacco-
free youth' and the hand bill had the caption 'The tobacco
Table 1: Awareness responses according to level of study
200 Level
n (%)
300 Level
n (%)
400 Level
n (%)
500 Level
n (%)
Total
n (%)
Aware of Tobacco Induced Diseases 80 (94.1) 92 (91.4) 46 (95.8) 61 (96.8) 279 (95.9)
Aware of World No Tobacco Day 9 (10.6) 9 (9.5) 3 (6.3) 5 (8.2) 26 (9.0)
Aware of Nigeria Tobacco decree 6 (7.1) 8 (8.4) 2 (4.2) 2 (3.7) 18 (6.3)
Aware of WHO FCTC 6 (7.1) 13 (13.7) 3 (6.4) 5 (8.1) 27 (9.3)
Table 2: Agreement responses to willingness or attitudinal questions according to level of study
Questions 200 Level
n (%)
300 Level
n (%)
400 Level
n (%)
500 Level
n (%)
Total
n (%)
Tobacco should not be sold in pharmacies 64 (75.3) 63 (67.0) 40 (83.3) 58 (93.6) 230 (77.9)
No smoking in pharmacy 72 (84.7) 79 (83.2) 44 (91.7) 61 (96.8) 256 (87.9)
pharmacists should not smoke 72 (84.7) 80 (84.2) 38 (79.2) 52 (82.54) 242 (83.2)
Smoking cessation counseling should be in pharmacy curriculum 77 (90.6) 80 (84.2) 40 (85.1) 57 (91.94) 254 (87.9)
No smoking at pharmacy students' events 72 (84.7) 83 (88.3) 40 (83.4) 57 (90.4) 252 (86.9)
It is your duty to be involved in smoking cessation program 76 (89.5) 87 (91.6) 47 (97.9) 62 (98.4) 272 (93.5)
Pharmacists and pharmacy students should be involved in quit smoking program 78 (91.7) 86 (88.5) 46 (95.8) 61 (96.8) 271 (93.1)
Willing to help smokers to quit 71 (83.5) 83 (87.4) 40 (83.3) 55 (88.7) 249 (85.9)Tobacco Induced Diseases 2009, 5:13 http://www.tobaccoinduceddiseases.com/content/5/1/13
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Industries catches you young'; 'Break The Tobacco Market-
ing Net' and 'Ban all tobacco advertising, promotion and
sponsoring for a tobacco free youth' [7].
This result is also comparable to the 3% prevalence Faseru
et al obtained in a survey on second to sixth year medical
students of University of Ibadan [16].
The prevalence is desirably low especially when compared
to what is obtained in similar works done in developed
countries, for instance, in a survey done among medical
students in a south German University, a prevalence of
17.6% was obtained among female students and 29.2%
among male participants [17]. Also in surveys carried out
in ten WHO member countries it was found that smoking
prevalence was higher than 20% in seven of the 10 coun-
tries surveyed [5].
Comparing the smoking prevalence obtained in this study
to that of the general Nigerian population which accord-
ing to 1998 survey [18] was 15% among males and 2%
among females one may say smoking is not common
among pharmacy students. However, according to Faseru
et al [16], there is need to intensify prevention and control
efforts because of the potentials of escalation of smoking
rates due to aggressive marketing strategies of emerging
big tobacco industry.
Also of note is the fact that, these are future healthcare
professionals and one smoking pharmacist for instance
would have a profound influence on the smoking habits
of his hundreds of patients/clients in the general popu-
lace. Health professional who continues to smoke sends
inconsistent message to patients whom he/she counsels.
Current smoking among the female participants in this
survey was nil compared to 5.5% obtained among the
male students, this further establishes the fact that tobacco
smoking prevalence in Nigeria is lesser among females
than males and this means more attention needs to be
given to the males in prevention and controlling tobacco
smoking.
As regards the distribution of smoking status across course
of study, the prevalence is highest among the 200 level
students but it is expected that this prevalence would have
reduced by the time these ones are getting to higher levels
as is shown in Figure 4 whereby the frequency of those
still smoking was reduced more in the higher levels.
Majority of those that have actually ever smoked started
before entering the University and most especially at the
secondary school level, some even started smoking before
the age of 10 years this implies that there is need to start
health education on harmful effect of smoking at least
right from primary school if not kindergarten.
Over 90% of the current smokers smoke between 1–5 cig-
arettes per day and only 6% smoke over 20 cigarettes per
day. About 89% of those that have stopped smoking were
smoking between 1–5 cigarettes per day and 5% were
smoking 6–10 and 11–15 sticks of cigarette per day. This
is important in the sense that it is one of the indicators of
nicotine addiction in Fagerstrom nicotine addiction test
[19]. From this result it can be said that only about 6% of
current smokers might be maximally addicted to nicotine
based on Fagerstrom nicotine addiction test.
It should be noted that the less addicted one is, the easier
it becomes to quit smoking, so, there is hope that the few
current smokers among pharmacy students would be easy
to counsel and convince to stop smoking and we might
end up having none of the pharmacy students being
smokers.
From the result, the response to awareness of Nigeria
tobacco decree and WHO FCTC was quite low. The stu-
dents not being aware of Nigeria tobacco Decree may not
be able to counsel and help spread or enforce the decree
for example the decree says no smoking in public places
[20].
The response to each attitudinal question addressing the
main thrust of these local and global policies were quite
favourable which implies that there would be minimal
effort necessary to convince pharmacy students of the
University of Lagos to abide with the code of conduct for
health care professionals and also to be in line with year
2007 theme for world no tobacco day which was 'smoke
free environments' since majority of the students agreed
that there should be no smoking at pharmacy students'
events and in pharmacies.
They will serve as good counsellors that the public may
rely on or believe in since majority of them do not smoke
and also most of them are willing to be involved in smok-
ing cessation program.
Over 85% of pharmacy students agreed that patient coun-
selling about smoking cessation should be included in
pharmacy curriculum, this compared favourably with the
results of the survey of ten WHO member countries where
about 93% thought health professionals should receive
cessation counselling training as part of their normal cur-
riculum [13].
Over 93% of pharmacy students agreed that pharmacists
and pharmacy students should be involved in quit smok-
ing programme and this is similar to the report of the sur-
vey of 10 WHO member countries where about 86 to 99%
believed that health professionals should give advice or
information about smoking cessation to patients [13].
The result is also similar to the report of survey of pharma-Tobacco Induced Diseases 2009, 5:13 http://www.tobaccoinduceddiseases.com/content/5/1/13
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cists in Lagos State whereby 98% agreed that pharmacists
should be involved in the global campaign against smok-
ing programme [21].
In the results of this study there was no significant differ-
ence in the agreement of the students at different levels of
study which implied that the students at different levels
agreed to the points that patient counselling about smok-
ing cessation should be included in pharmacy curriculum,
pharmacists and pharmacy students should be involved
in quit smoking programme and are willing to be
involved in smoking cessation program.
Conclusion
From this study it can be concluded that smoking preva-
lence is low among pharmacy students and is even nil in
females at the University of Lagos. The prevalence is high-
est among the 200 level students
It can also be concluded from the result of this study that
though level of awareness of pharmacy students at the
University of Lagos of global smoking policy is low but
their attitude towards the contents of the policy is highly
favourable. They are willing to keep a smoke free environ-
ment, promote a tobacco free future and be involved in
smoking cessation programme and this cuts across all the
levels.
It is being recommended that smoking cessation pro-
gramme should be included in pharmacy curriculum.
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